Research Program
Healthcare Markets Initiative
U.S. healthcare markets suffer from both overuse and underuse. The challenge is developing the appropriate incentives that eliminate the inefficiencies which lead to some services being too expensive and reimbursements for other services being too low. The Healthcare Markets Initiative advances market-based solutions to health policy challenges in a variety of areas including rare diseases, medical devices and mental health.
Upcoming Events
Program Leadership
-
Matthew Kahn, PhD
Director, Healthcare Markets Initiative, USC Schaeffer Center
Provost Professor of Economics and Spatial Sciences, USC Dornsife College of Letters, Arts, and Science -
Jakub Hlávka, PhD
Executive Director, Healthcare Markets Initiative, USC Schaeffer Center
Research Assistant Professor, Health Policy and Management, USC Price School of Public Policy
Research Fellow, USC Center for Risk and Economic Analysis of Threats and Emergencies (CREATE)
Healthcare Markets Researchers
-
Joseph Grogan, JD
Nonresident Senior Fellow, USC Schaeffer Center
Former Assistant, U.S. President
Former Director, Domestic Policy Council (DPC) -
Darius Lakdawalla, PhD
Director, Research, USC Schaeffer Center
Quintiles Chair in Pharmaceutical Development and Regulatory Innovation, USC School of Pharmacy
Professor, USC Price School of Public Policy
Medical Device Regulation and Reimbursement: What the Pandemic Revealed
Schaeffer Center Nonresident Senior Fellow and Former Director of the Domestic Policy Council Joe Grogan and AEI Senior Fellow and Former FDA Commissioner Scott Gottlieb joined Schaeffer Center Co-Director Erin Trish to discuss the challenges and opportunities facing the FDA and CMS in an age of breakthrough medical devices.
Read Full StoryGet Involved
Learn more about HMI, including opportunities to collaborate